COLL Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will present at the following investor conferences in April:

• The H.C. Wainwright Global Life Sciences Conference on Monday, April 8th at 11:10 a.m. GMT in London 
• The Needham Healthcare Conference on Wednesday, April 10th at 2:50 p.m. EDT in New York City

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact: Alex Dasalla adasalla@collegiumpharma.com